Dianthus Therapeutics (DNTH) Leases (2022 - 2025)
Historic Leases for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to $1.3 million.
- Dianthus Therapeutics' Leases rose 27102.27% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 27102.27%. This contributed to the annual value of $1.6 million for FY2024, which is 15252.03% up from last year.
- Dianthus Therapeutics' Leases amounted to $1.3 million in Q3 2025, which was up 27102.27% from $1.4 million recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' Leases peaked at $25.4 million during Q1 2022, and registered a low of $352000.0 during Q3 2024.
- Over the past 4 years, Dianthus Therapeutics' median Leases value was $1.3 million (recorded in 2025), while the average stood at $6.4 million.
- As far as peak fluctuations go, Dianthus Therapeutics' Leases plummeted by 9708.32% in 2023, and later soared by 27102.27% in 2025.
- Quarter analysis of 4 years shows Dianthus Therapeutics' Leases stood at $814000.0 in 2022, then decreased by 24.45% to $615000.0 in 2023, then skyrocketed by 152.52% to $1.6 million in 2024, then fell by 15.9% to $1.3 million in 2025.
- Its last three reported values are $1.3 million in Q3 2025, $1.4 million for Q2 2025, and $1.4 million during Q1 2025.